These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31980996)
1. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy. Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996 [TBL] [Abstract][Full Text] [Related]
2. Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance. Wheler J; Yelensky R; Falchook G; Kim KB; Hwu P; Tsimberidou AM; Stephens PJ; Hong D; Cronin MT; Kurzrock R BMC Cancer; 2015 Feb; 15():61. PubMed ID: 25886620 [TBL] [Abstract][Full Text] [Related]
3. NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay. Olbryt M; Rajczykowski M; Bal W; Fiszer-Kierzkowska A; Cortez AJ; Mazur M; Suwiński R; Widłak W Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356096 [TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma. Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain. Castrejon N; Martin R; Carrasco A; Castillo P; Garcia A; Albero-González R; García M; Marginet M; Palau N; Hernández M; Montironi C; Clot G; Arance A; Alos L; Teixido C Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000050 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients. Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269 [TBL] [Abstract][Full Text] [Related]
9. Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing. Jauhri M; Bhatnagar A; Gupta S; Shokeen Y; Minhas S; Aggarwal S Med Oncol; 2016 Oct; 33(10):106. PubMed ID: 27568332 [TBL] [Abstract][Full Text] [Related]
10. Validation of an NGS mutation detection panel for melanoma. Reiman A; Kikuchi H; Scocchia D; Smith P; Tsang YW; Snead D; Cree IA BMC Cancer; 2017 Feb; 17(1):150. PubMed ID: 28228113 [TBL] [Abstract][Full Text] [Related]
11. The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response. Pinto R; De Summa S; Strippoli S; Pilato B; Azzariti A; Guida G; Guida M; Tommasi S Oncotarget; 2016 May; 7(18):25135-49. PubMed ID: 26863566 [TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma. Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747 [TBL] [Abstract][Full Text] [Related]
13. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach. Manca A; Paliogiannis P; Colombino M; Casula M; Lissia A; Botti G; Caracò C; Ascierto PA; Sini MC; Palomba G; Pisano M; ; ; Doneddu V; Cossu A; Palmieri G; J Transl Med; 2019 Aug; 17(1):289. PubMed ID: 31455347 [TBL] [Abstract][Full Text] [Related]
14. High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients. van den Hurk K; Balint B; Toomey S; O'Leary PC; Unwin L; Sheahan K; McDermott EW; Murphy I; van den Oord JJ; Rafferty M; FitzGerald DM; Moran J; Cummins R; MacEneaney O; Kay EW; O'Brien CP; Finn SP; Heffron CC; Murphy M; Yela R; Power DG; Regan PJ; McDermott CM; O'Keeffe A; Orosz Z; Donnellan PP; Crown JP; Hennessy BT; Gallagher WM Melanoma Res; 2015 Jun; 25(3):189-99. PubMed ID: 25746038 [TBL] [Abstract][Full Text] [Related]
15. Mutational profiling of acral melanomas in Korean populations. Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690 [TBL] [Abstract][Full Text] [Related]
16. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study. Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G; BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929 [TBL] [Abstract][Full Text] [Related]
17. Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing. Taher MM; Bantan NA; Alwalily MH; Saeed M; Taher NM; Bouzidi M; Jastania RA; Balkhoyour KB Cureus; 2023 Jun; 15(6):e39818. PubMed ID: 37273678 [TBL] [Abstract][Full Text] [Related]
18. Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. Raaijmakers MI; Widmer DS; Narechania A; Eichhoff O; Freiberger SN; Wenzina J; Cheng PF; Mihic-Probst D; Desalle R; Dummer R; Levesque MP Oncotarget; 2016 Nov; 7(47):77163-77174. PubMed ID: 27791198 [TBL] [Abstract][Full Text] [Related]
19. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract. Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. Yaman B; Akalin T; Kandiloğlu G Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]